Sweden
# |
Name |
Interest Coverage Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
14,690.50
|
Dec. 31, 2023 | USD 5.03 | -0.03% |
|
Sweden |
|
2 |
8,179.64
|
Dec. 31, 2023 | USD 0.53 | -1.00% |
|
Sweden |
|
3 |
2,186.75
|
Dec. 31, 2023 | USD 0.69 | 3.06% |
|
Sweden |
|
4 |
1,868.09
|
Dec. 31, 2023 | USD 9.48 | 0.49% |
|
Sweden |
|
5 |
926.50
|
Dec. 31, 2023 | USD 0.34 | 2.30% |
|
Sweden |
|
6 |
889.78
|
Dec. 31, 2023 | USD 7.30 | 0.92% |
|
Sweden |
|
7 |
812.80
|
Dec. 31, 2023 | USD 2.85 | 0.68% |
|
Sweden |
|
8 |
730.51
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
9 |
580.52
|
Dec. 31, 2023 | USD 9.75 | -0.95% |
|
Sweden |
|
10 |
431.88
|
Dec. 31, 2023 | USD 51.72 | -0.10% |
|
Sweden |
|
11 |
409.94
|
Dec. 31, 2023 | USD 13.49 | 0.81% |
|
Sweden |
|
12 |
315.72
|
Dec. 31, 2023 | USD 16.17 | -0.15% |
|
Sweden |
|
13 |
279.35
|
Dec. 31, 2023 | USD 32.66 | 2.35% |
|
Sweden |
|
14 |
274.00
|
Dec. 31, 2023 | USD 4.16 | 1.50% |
|
Sweden |
|
15 |
253.33
|
Dec. 31, 2023 | USD 0.16 | -2.12% |
|
Sweden |
|
16 |
228.04
|
Dec. 31, 2023 | USD 76.06 | 1.75% |
|
Sweden |
|
17 |
207.88
|
Dec. 31, 2023 | USD 0.47 | 0.81% |
|
Sweden |
|
18 |
157.43
|
April 30, 2024 | USD 22.17 | -0.20% |
|
Sweden |
|
19 |
137.78
|
Dec. 31, 2023 | USD 31.81 | -0.30% |
|
Sweden |
|
20 |
117.04
|
Dec. 31, 2023 | USD 10.50 | 2.24% |
|
Sweden |
|
21 |
116.90
|
Dec. 31, 2023 | USD 2.57 | -0.02% |
|
Sweden |
|
22 |
107.25
|
Dec. 31, 2023 | USD 9.44 | 1.16% |
|
Sweden |
|
23 |
97.50
|
June 30, 2024 | USD 3.46 | 1.94% |
|
Sweden |
|
24 |
97.34
|
Dec. 31, 2023 | USD 3.83 | -1.61% |
|
Sweden |
|
25 |
89.45
|
Dec. 31, 2023 | USD 2.11 | 2.63% |
|
Sweden |
|
26 |
87.11
|
Dec. 31, 2023 | USD 4.61 | 2.06% |
|
Sweden |
|
27 |
86.28
|
Dec. 31, 2023 | USD 204.93 | 1.56% |
|
Sweden |
|
28 |
84.00
|
Dec. 31, 2023 | USD 41.34 | 0.25% |
|
Sweden |
|
29 |
81.60
|
Dec. 31, 2023 | USD 0.63 | 1.98% |
|
Sweden |
|
30 |
79.14
|
Dec. 31, 2023 | USD 0.20 | -5.10% |
|
Sweden |
|
31 |
77.00
|
Dec. 31, 2023 | USD 26.55 | 2.40% |
|
Sweden |
|
32 |
71.58
|
Dec. 31, 2023 | USD 12.74 | 1.39% |
|
Sweden |
|
33 |
69.41
|
Dec. 31, 2023 | USD 2.88 | 0.37% |
|
Sweden |
|
34 |
64.77
|
Dec. 31, 2023 | USD 20.31 | 6.27% |
|
Sweden |
|
35 |
64.22
|
Dec. 31, 2023 | USD 19.05 | 2.21% |
|
Sweden |
|
36 |
62.64
|
Dec. 31, 2023 | USD 5.99 | 1.28% |
|
Sweden |
|
37 |
61.40
|
Dec. 31, 2023 | USD 4.45 | 1.90% |
|
Sweden |
|
38 |
60.38
|
Dec. 31, 2023 | USD 24.72 | 1.01% |
|
Sweden |
|
39 |
59.49
|
Dec. 31, 2023 | USD 36.51 | 2.02% |
|
Sweden |
|
40 |
56.99
|
Dec. 31, 2023 | USD 0.90 | 2.09% |
|
Sweden |
|
41 |
54.48
|
Dec. 31, 2023 | USD 0.76 | 0.68% |
|
Sweden |
|
42 |
51.37
|
Dec. 31, 2023 | USD 18.76 | 3.89% |
|
Sweden |
|
43 |
48.03
|
Dec. 31, 2023 | USD 20.04 | 0.59% |
|
Sweden |
|
44 |
47.99
|
Dec. 31, 2023 | USD 36.35 | -2.10% |
|
Sweden |
|
45 |
47.95
|
Dec. 31, 2023 | USD 9.91 | 1.41% |
|
Sweden |
|
46 |
42.21
|
Dec. 31, 2023 | USD 42.37 | 0.78% |
|
Sweden |
|
47 |
41.37
|
Dec. 31, 2023 | USD 6.29 | -0.17% |
|
Sweden |
|
48 |
40.78
|
Dec. 31, 2023 | USD 15.69 | 1.43% |
|
Sweden |
|
49 |
40.76
|
Dec. 31, 2023 | USD 3.33 | 0.41% |
|
Sweden |
|
50 |
39.84
|
Dec. 31, 2023 | USD 10.74 | 1.10% |
|
Sweden |
The company in Sweden with the highest Interest Coverage Ratio is Generic Sweden AB (Stockholm Stock Exchange: GENI.ST) at 14,690.50.
The company in Sweden with the lowest Interest Coverage Ratio is BeammWave AB (publ) (Stockholm Stock Exchange: BEAMMW-B.ST) at -84,926.39.
The top 10 companies in Sweden by Interest Coverage Ratio are Generic Sweden AB, AVTECH Sweden AB (publ), Diadrom Holding AB (publ), Investment AB Öresund (publ), Effnetplattformen Holding AB (publ), Solid Försäkringsaktiebolag (publ), Upsales Technology AB (publ), BioArctic AB (publ), BioGaia AB (publ) and Camurus AB (publ).
The bottom 10 companies in Sweden by Interest Coverage Ratio are BeammWave AB (publ), Gapwaves AB (publ), NextCell Pharma AB, Nepa AB (publ), Ascelia Pharma AB (publ), CombiGene AB (publ), Chordate Medical Holding AB (publ), Minesto AB (publ), BoMill AB (publ) and IRLAB Therapeutics AB (publ).